Predicting novel candidate human obesity genes and their site of action by systematic functional screening in Drosophila.
Predicting novel candidate human obesity genes and their site of action by systematic functional screening in Drosophila.
复制标题
DOI:
10.1371/journal.pbio.3001255
复制
发表时间:
2021-11
期刊:
影响因子:
9.8
通讯作者:
Brand AH
中科院分区:
文献类型:
--
作者:
Agrawal N;Lawler K;Davidson CM;Keogh JM;Legg R;INTERVAL;Barroso I;Farooqi IS;Brand AH
The discovery of human obesity-associated genes can reveal new mechanisms to target for weight loss therapy. Genetic studies of obese individuals and the analysis of rare genetic variants can identify novel obesity-associated genes. However, establishing a functional relationship between these candidate genes and adiposity remains a significant challenge. We uncovered a large number of rare homozygous gene variants by exome sequencing of severely obese children, including those from consanguineous families. By assessing the function of these genes in vivo in Drosophila, we identified 4 genes, not previously linked to human obesity, that regulate adiposity (itpr, dachsous, calpA, and sdk). Dachsous is a transmembrane protein upstream of the Hippo signalling pathway. We found that 3 further members of the Hippo pathway, fat, four-jointed, and hippo, also regulate adiposity and that they act in neurons, rather than in adipose tissue (fat body). Screening Hippo pathway genes in larger human cohorts revealed rare variants in TAOK2 associated with human obesity. Knockdown of Drosophila tao increased adiposity in vivo demonstrating the strength of our approach in predicting novel human obesity genes and signalling pathways and their site of action. This study set out to identify novel gene variants that may contribute to human obesity, by combining human exosome sequencing analyses with systematic functional screening in Drosophila. This identifies a number of novel obesity-associated genes which control adiposity in flies, and uncovers a potential role for the Hippo signaling pathway in obesity.
登录
查看更多内容
DOI:
10.1073/pnas.0702726104
发表时间:
2007-05-15
影响因子:
11.1
作者:
Ja, William W.;Carvalho, Gil B.;Benzer, Seymour
通讯作者:
Benzer, Seymour
DOI:
10.1016/s0140-6736(17)31928-1
发表时间:
2017-11-25
期刊:
Lancet (London, England)
影响因子:
--
作者:
Di Angelantonio E;Thompson SG;Kaptoge S;Moore C;Walker M;Armitage J;Ouwehand WH;Roberts DJ;Danesh J;INTERVAL Trial Group
通讯作者:
INTERVAL Trial Group
影响因子:
4.5
作者:
Baranski TJ;Kraja AT;Fink JL;Feitosa M;Lenzini PA;Borecki IB;Liu CT;Cupples LA;North KE;Province MA
通讯作者:
Province MA
影响因子:
16.2
作者:
Al-Anzi, Bader;Sapin, Viveca;Waters, Christopher;Zinn, Kai;Wyman, Robert J.;Benzer, Seymour
通讯作者:
Benzer, Seymour
影响因子:
9.8
作者:
Finegan, Tara M.;Hervieux, Nathan;Sanson, Benedicte
通讯作者:
Sanson, Benedicte